ConductScience.org, home

Library / Genes

DNM1L: dynamin 1L

1 protein, 27 patents, 0 drugs, 0 trials, 3,390 NIH grants and 6,741 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolDNM1LHGNC
Namedynamin 1LHGNC
NCBI Gene ID10059NCBI Gene
HGNC IDHGNC:2973HGNC
EnsemblENSG00000087470NCBI Gene
AliasesDLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1, HDYNIV, OPA5, VPS1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
O00429Dynamin-1-like protein73611Ensembl, GeneID, HGNCUniProt

Patents 27

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026515744 A2026-05-19292O00429Espacenet
JP 2026004568 A2026-01-1444417O00429Espacenet
EP 4650780 A22025-11-1916642O00429Espacenet
JP 2025517970 A2025-06-1216642O00429Espacenet
JP 2025062601 A2025-04-1442O00429Espacenet
WO 2024214081 A12024-10-17292O00429Espacenet
JP 2024056774 A2024-04-2315O00429Espacenet
US 11834502 B22023-12-05111O00429Espacenet
US 11446398 B22022-09-2025961O00429Espacenet
JP 2022524081 A2022-04-27128932O00429Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3390

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
R01GM125844Defining Molecular Interactions that Drive Mitochondrial Fission152,025NIH's project files
ZIANS002859Targeting Protein Aggregates for Autophagosomal Degradation142,025NIH's project files
P30CA047904Cancer Center Support Grant112,025NIH's project files
R35GM128915Molecular Principles Governing Mitochondrial and Peroxisomal Remodeling as Drivers of Cell Fate and Identity112,025NIH's project files
P40OD010440Caenorhabditis Genetics Center102,025NIH's project files
P20GM113132The Institute for Biomolecular Targeting92,025NIH's project files
ZIANS003123Role of mitochondria in neurodegenerative diseases92,025NIH's project files
P30AG028740University of Florida Older Americans Independence Center (OAIC)82,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program82,025NIH's project files
P30CA023108Cancer Center Support Grant72,025NIH's project files

Papers 6741

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42816872PubTator, text miningPubMed
42815786PubTator, text miningPubMed
42777858PubTator, text miningPubMed
42762130PubTator, text miningPubMed
42761440PubTator, text miningPubMed
42753306PubTator, text miningPubMed
42751568PubTator, text miningPubMed
42725127PubTator, text miningPubMed
42723548PubTator, text miningPubMed
42704293PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license